Capitol Health Gears Up for Shareholder Merger Vote

Capitol Health Limited (AU:CAJ) has released an update.

Capitol Health Limited has announced a merger with Integral Diagnostics Limited, subject to shareholder approval at a Scheme Meeting after the Federal Court of Australia’s green light. The company’s directors unanimously endorse the merger, emphasizing its fairness and reasonableness as assessed by an Independent Expert’s Report from KPMG. Shareholders will receive detailed materials and are encouraged to review them before the Scheme Meeting scheduled for 31 October 2024.

For further insights into AU:CAJ stock, check out TipRanks’ Stock Analysis page.